Literature DB >> 16352460

Molecular survival strategies of Echinococcus multilocularis in the murine host.

Bruno Gottstein1, Karen Haag, Mirjam Walker, Jun Matsumoto, Naceur Mejri, Andrew Hemphill.   

Abstract

Larval infection with Echinococcus multilocularis starts with the intrahepatic postoncospheral development of a metacestode that-at its mature stage-consists of an inner germinal and an outer laminated layer (GL & LL). In certain cases, an appropriate host immune response may inhibit parasite proliferation. Several lines of evidence obtained in vivo and in vitro indicate the important bio-protective role of the LL. For instance, the LL has been proposed to protect the GL from nitric oxide produced by periparasitic macrophages and dendritic cells, and also to prevent immune recognition by surrounding T cells. On the other hand, the high periparasitic NO production by peritoneal exsudate cells contributes to periparasitic immunosuppression, explaining why iNOS deficienct mice exhibit a significantly lower susceptibility towards experimental infection. The intense periparasitic granulomatous infiltration indicates a strong host-parasite interaction, and the involvement of cellular immunity in control of the metacestode growth kinetics is strongly suggested by experiments carried out in T cell deficient mouse strains. Carbohydrate components of the LL, such as Em2(G11) and Em492, as well as other parasite metabolites yield immunomodulatory effects that allow the parasite to survive in the host. I.e., the IgG response to the Em2(G11)-antigen takes place independently of alpha-beta+CD4+T cells, and in the absence of interactions between CD40 and CD40 ligand. Such parasite molecules also interfere with antigen presentation and cell activation, leading to a mixed Th1/Th2-type response at the later stage of infection. Furthermore, Em492 and other (not yet published) purified parasite metabolites suppress ConA and antigen-stimulated splenocyte proliferation. Infected mouse macrophages (AE-MØ) as antigen presenting cells (APC) exhibited a reduced ability to present a conventional antigen (chicken ovalbumin, C-Ova) to specific responder lymph node T cells when compared to normal MØ. As AE-MØ fully maintain their capacity to appropriately process antigens, a failure in T cell receptor occupancy by antigen-Ia complex or/and altered co-stimulatory signals can be excluded. Studying the status of accessory molecules implicated in T cell stimulation by MØ, it could be shown that B7-1 (CD80) and B7-2 (CD86) remained unchanged, whereas CD40 was down-regulated and CD54 (=ICAM-1) slightly up-regulated. FACS analysis of peritoneal cells revealed a decrease in the percentage of CD4+ and CD8+T cells in AE-infected mice. Taken together the obstructed presenting-activity of AE-MØ appeared to trigger an unresponsiveness of T cells leading to the suppression of their clonal expansion during the chronic phase of AE infection. Interesting information on the parasite survival strategy and potential can be obtained upon in vitro and in vivo treatment. Hence, we provided very innovative results by showing that nitazoxanide, and now also, respectively, new modified compounds may represent a useful alternative to albendazole. In the context of chemotherapeutical repression of parasite growth, we searched also for parasite molecules, whose expression levels correlate with the viability and growth activity of E. multilocularis metacestode. Expression levels of 14-3-3 and II/3-10, relatively quantified by realtime reverse transcription-PCR using a housekeeping gene beta-actin, were studied in permissive nu/nu and in low-permissive wild type BALB/c mice. At 2 months p.i., the transcription level of 14-3-3 was significantly higher in parasites actively proliferating in nu/nu mice compared to parasites moderately growing in wild type mice. Immunoblotting experiments confirmed at the protein level that 14-3-3 was over-expressed in parasites derived from nu/nu mice at 2 months p.i. In vitro-treatment of E. multilocularis with an anti-echinococcal drug nitazoxanide for a period of 8 days resulted in a significant decrease of both 14-3-3 and II/3-10 transcription levels, which correlated with the kinetics of a housekeeping gene, beta-actin. This indicates that 14-3-3-exhibits a good potential as a molecular marker to assess viability and growth activity of the parasite.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352460     DOI: 10.1016/j.parint.2005.11.006

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  15 in total

1.  Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.

Authors:  Xiangsheng Huang; Beate Grüner; Christian J Lechner; Peter Kern; Peter T Soboslay
Journal:  Med Microbiol Immunol       Date:  2014-02-09       Impact factor: 3.402

2.  Modulation of dendritic cell differentiation and cytokine secretion by the hydatid cyst fluid of Echinococcus granulosus.

Authors:  João H C Kanan; Benjamin M Chain
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

3.  Immunomodulative effect of glucan and/or glucan supplemented with zinc in albendazole therapy for murine alveolar echinococcosis.

Authors:  Jarmila Porubcová; Emília Dvoroznáková; Zuzana Sevcíková
Journal:  Parasitol Res       Date:  2007-05-12       Impact factor: 2.289

4.  Imunomodulative effect of liposomized muramyltripeptide phosphatidylethanolamine (L-MTP-PE) on mice with alveolar echinococcosis and treated with albendazole.

Authors:  Emília Dvoroznáková; Jarmila Porubcová; Viliam Snábel; Peter Fedorocko
Journal:  Parasitol Res       Date:  2008-06-29       Impact factor: 2.289

5.  Immune response of mice with alveolar echinococcosis to therapy with transfer factor, alone and in combination with albendazole.

Authors:  Emília Dvoroznáková; Jarmila Porubcová; Zuzana Sevcíková
Journal:  Parasitol Res       Date:  2009-06-23       Impact factor: 2.289

6.  Mucosal adjuvanticity of fibronectin-binding peptide (FBP) fused with Echinococcus multilocularis tetraspanin 3: systemic and local antibody responses.

Authors:  Zhisheng Dang; Jinchao Feng; Kinpei Yagi; Chihiro Sugimoto; Wei Li; Yuzaburo Oku
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

7.  Sensitive and specific immunohistochemical diagnosis of human alveolar echinococcosis with the monoclonal antibody Em2G11.

Authors:  Thomas F E Barth; Tobias S Herrmann; Dennis Tappe; Lorenz Stark; Beate Grüner; Klaus Buttenschoen; Andreas Hillenbrand; Markus Juchems; Doris Henne-Bruns; Petra Kern; Hanns M Seitz; Peter Möller; Robert L Rausch; Peter Kern; Peter Deplazes
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25

8.  Excretory/secretory-products of Echinococcus multilocularis larvae induce apoptosis and tolerogenic properties in dendritic cells in vitro.

Authors:  Justin Komguep Nono; Katrien Pletinckx; Manfred B Lutz; Klaus Brehm
Journal:  PLoS Negl Trop Dis       Date:  2012-02-21

9.  A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology.

Authors:  Zhisheng Dang; Kinpei Yagi; Yuzaburo Oku; Hirokazu Kouguchi; Kiichi Kajino; Jun Matsumoto; Ryo Nakao; Hiroyuki Wakaguri; Atsushi Toyoda; Hong Yin; Chihiro Sugimoto
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

10.  Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen.

Authors:  Ghalia Boubaker; Andrew Hemphill; Cristina Olivia Huber; Markus Spiliotis; Hamouda Babba; Bruno Gottstein
Journal:  PLoS Negl Trop Dis       Date:  2015-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.